Anne LERMET

En résumé

Entreprises

• AB Science - Clinical Research Associate Coordinator

  2009 - maintenant Fields : Oncology, Pneumology, Rheumatology, MS
  • National and international studies, phase II to III according to GCP/ICH
  • Site Selection, Initiation, Monitoring and Close-Out visits
  • Submissions to EC and CA
  • Budget management and Negotiation of CTA with hospitals and investigators
  • Management of trial's logistics (central labs, IMP, questionnaires, copyrights, printing,...)
  • Preparation of study documents and tools (Protocol, traductions, Inform consent form, investigators leaflet, monitoring guidelines, e-CRF, IWRS). Management of TMFs
  • Participation to the preparation of inspections, audits and regulatory files

• ABscience - Ingénieur de recherche

  2002 - 2009 • Process optimization and technology transmission to subcontractor, targeted and selective biological activity improvement, pharmacokinetic and pharmacodynamic properties improvement on lead products
  • Interface between chemistry, biology and modeling teams, technology intelligence on specific company field, negotiation of prices for procurement of products and materials
  • management of technicians and interns, team safety manager
  • 6 patents, publication on lead product which obtained veterinary marketing authorization

• Bayer AG - Research Scientist

  Lyon 1999 - 1999 Project targeting GPCRs to investigate multiple diseases (obesity,...) during gap year
  

• Wayne State University - Research and Teaching Assistant

  1999 - 2001 Project of master of science on antibiotic compounds
  Teaching Assistant at university level

Formations

• For Drug Consulting

  Malakoff 2009 - 2009 Clinical Research - training on the different steps of management of clinical studies according to GCP/ICH ( site selection, site initiation presentation, monitoring, close out visit, TMF management)

• Université Lyon 1 Claude Bernard

  Villeurbanne 2003 - 2006 Thèse de Doctorat
  
  Medicinal chemistry - Development of new families of Tyrosine Kinase Inhibitors for the treatment of cancers and inflammatory diseases, supervised by Pr Marco Ciufolini

• Wayne State University (Detroit)

  Detroit 1999 - 2001 Master of Science
  
  New pathway for the synthesis of an antibiotic, seminars presentation

• University Of Salford (Salford, Greater Manchester)

  Salford, Greater Manchester 1998 - 1999 2nd year of BSc inside a dual program
  
  BSc in biological sciences

• Chimie Physique Electronique De Lyon

  Villeurbanne 1996 - 2001 Ingénieur Chimie et Génie des procédés

Réseau

• Doriane RICHARD

• Droumaguet-Grégoire CATHERINE

• Estelle RICCI

• Laura MICHAUD

• Laure ABILY-MEYER

• Lucie LUCIE VANDROMME (VANDROMME)

• Malika SASSI

• Marie SOMPHANTHABAMSOUK

• Sannaa EL MAAROUFI ELIDRISSI

• Sylvie KAHN